The exon 45 skipping therapy of induced pluripotent stem cells derived cardiomyocyte from the DMD patient with exon 46-55 deletion
Page 1 of 1
The exon 45 skipping therapy of induced pluripotent stem cells derived cardiomyocyte from the DMD patient with exon 46-55 deletion
Jon Moulton Fri Dec 08, 2017 10:50 am
Sato M, Miyazaki D, Shiba Y, Echigoya Y, Yokota T, Aoki Y, Takeda S, Nakamura A. The exon 45 skipping therapy of induced pluripotent stem cells derived cardiomyocyte from the DMD patient with exon 46-55 deletion. J Neurol Sci. 2017;381suppl:142. doi:10.1016/j.jns.2017.08.420
Jon Moulton- Posts : 5721
Join date : 2010-03-12
Age : 61
Location : Philomath, Oregon, USA -
Similar topics» Generation of Human Induced Pluripotent Stem Cells Using Epigenetic Regulators Reveals a Germ Cell-Like Identity in Partially Reprogrammed Colonies
» Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
» Exon-skipping therapy for Duchenne muscular dystrophy
» ALPK2 Promotes Cardiogenesis in Zebrafish and Human Pluripotent Stem Cells
» Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
» Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
» Exon-skipping therapy for Duchenne muscular dystrophy
» ALPK2 Promotes Cardiogenesis in Zebrafish and Human Pluripotent Stem Cells
» Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum